GlassScriptPhysician profile
Alison J Berndt
NPI 1568834588
$11,052.83
in general payments reported to CMS, 2019-2025
39 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,808 · 2022: $1,886 · 2023: $2,069 · 2024: $2,712 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,524 · Travel and Lodging: $579 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,523.64 |
| Travel and Lodging | $578.94 |
| Education | $256.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,028.72 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,313.73 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Inspire Medical Systems, INC. | $1,101.96 | 2021-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $876.18 | 2021-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $614.38 | 2021-2025 | |
| Grifols USA, LLC | $610.33 | 2021-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $452.43 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $410.24 | 2021-2025 | Glassia |
| Harmony Biosciences LLC | $401.71 | 2022-2025 | Wakix |
| Mylan Specialty L.P. | $394.85 | 2021-2024 | Yupelri |
| Axsome Therapeutics, INC. | $341.17 | 2022-2025 | Sunosi |
| Genzyme Corporation | $310.35 | 2021-2025 | |
| Baxter Healthcare | $264.41 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $175.72 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $165.36 | 2021-2025 | Acthar |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $158.77 | 2022-2025 | Brinsupri, Arikayce |
| Amgen INC. | $145.01 | 2022-2025 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $122.76 | 2024-2025 | Lumryz |
| Viatris Specialty LLC | $121.77 | 2025 | Yupelri |
| United Therapeutics Corporation | $116.13 | 2021-2024 | Tyvaso |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Genentech USA, INC. | $98.76 | 2021-2024 | Xolair |
| Electromed, INC. | $95.16 | 2022-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $88.80 | 2022 | |
| Verona Pharma, INC. | $85.71 | 2025 | Ohtuvayre |
| Idorsia Pharmaceuticals US INC | $71.74 | 2023-2024 | Quviviq |
| Inogen, INC. | $57.81 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vifor Pharma, INC. | $43.97 | 2024-2025 | Zemaira |
| Paratek Pharmaceuticals, INC. | $43.10 | 2022-2025 | Nuzyra |
| Optinose US, INC. | $34.39 | 2022 | |
| Lilly USA, LLC | $33.82 | 2025 | Zepbound |
| Shionogi INC | $30.78 | 2022 | |
| Philips North America LLC | $24.95 | 2021 | |
| Pharming Healthcare, INC. | $24.20 | 2022 | |
| Advanced Respiratory, INC | $22.18 | 2021 | |
| Resmed Corp | $18.82 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.60 | 2021 | |
| Tactile Systems Technology INC | $17.50 | 2022 | |
| Merck Sharp & Dohme LLC | $16.61 | 2024 | Zerbaxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Berndt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.